| scholarly article | Q13442814 |
| P50 | author | Alexandros Makriyannis | Q28480394 |
| P2093 | author name string | Patricia H Reggio | |
| Ankur Kapur | |||
| Mary E Abood | |||
| Derek M Shore | |||
| Jahan Marcu | |||
| Megan Trznadel | |||
| P2860 | cites work | Crystal structure of a lipid G protein-coupled receptor | Q24305457 |
| Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor | Q27646733 | ||
| Comparative protein modelling by satisfaction of spatial restraints | Q27860866 | ||
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction | Q27860958 | ||
| Structure of the third intracellular loop of the human cannabinoid 1 receptor | Q28201987 | ||
| Modeling of loops in protein structures | Q29615861 | ||
| International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 | ||
| Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation | Q30522852 | ||
| Third extracellular loop (EC3)-N terminus interaction is important for seven-transmembrane domain receptor function: implications for an activation microswitch region | Q34181416 | ||
| An Aromatic Microdomain at the Cannabinoid CB1 Receptor Constitutes an Agonist/Inverse Agonist Binding Region | Q34276219 | ||
| Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1. | Q34412157 | ||
| Structure of bovine rhodopsin in a trigonal crystal form. | Q34551940 | ||
| Ligand based structural studies of the CB1 cannabinoid receptor | Q35015783 | ||
| The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones | Q36176455 | ||
| Mapping the structural requirements in the CB1 cannabinoid receptor transmembrane helix II for signal transduction | Q37156730 | ||
| Emerging strategies for exploiting cannabinoid receptor agonists as medicines | Q37230665 | ||
| Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices. | Q37232161 | ||
| Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. | Q37250484 | ||
| Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization | Q37402780 | ||
| An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity | Q37825535 | ||
| Systematic analysis of the entire second extracellular loop of the V(1a) vasopressin receptor: key residues, conserved throughout a G-protein-coupled receptor family, identified. | Q40150862 | ||
| Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands | Q44351724 | ||
| Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A | Q44445739 | ||
| Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail | Q44550611 | ||
| Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling | Q45111274 | ||
| Mutation studies of Ser7.39 and Ser2.60 in the human CB1 cannabinoid receptor: evidence for a serine-induced bend in CB1 transmembrane helix 7. | Q46190274 | ||
| Cysteine residues in the human cannabinoid receptor: only C257 and C264 are required for a functional receptor, and steric bulk at C386 impairs antagonist SR141716A binding | Q46543271 | ||
| Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. | Q48918978 | ||
| GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor | Q54152464 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| Site of G protein binding to rhodopsin mapped with synthetic peptides from the alpha subunit | Q70399454 | ||
| Related contribution of specific helix 2 and 7 residues to conformational activation of the serotonin 5-HT2A receptor | Q71921157 | ||
| A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor | Q72258557 | ||
| Construction of a 3D model of the cannabinoid CB1 receptor: determination of helix ends and helix orientation | Q72302114 | ||
| Multiple residues in the second extracellular loop are critical for M3 muscarinic acetylcholine receptor activation | Q79527348 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| transmembrane protein | Q424204 | ||
| P304 | page(s) | 189-197 | |
| P577 | publication date | 2013-02-20 | |
| P1433 | published in | Journal of Pharmacology and Experimental Therapeutics | Q1500272 |
| P1476 | title | Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2 | |
| P478 | volume | 345 |
| Q34946743 | (4-(Bis(4-fluorophenyl)methyl)piperazin-1-yl)(cyclohexyl)methanone hydrochloride (LDK1229): a new cannabinoid CB1 receptor inverse agonist from the class of benzhydryl piperazine analogs. |
| Q89452220 | Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors |
| Q37608491 | Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling |
| Q89658357 | GPR6 Structural Insights: Homology Model Construction and Docking Studies |
| Q30842363 | Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe |
| Q38660494 | Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer |
| Q35013538 | Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols |
| Q90351873 | The F238L Point Mutation in the Cannabinoid Type 1 Receptor Enhances Basal Endocytosis via Lipid Rafts |
Search more.